Centre Hospitalier Henri Mondor — Clinical Trial Site

19 Registered trials

14 Currently recruiting

Organisation

Centre Hospitalier Henri Mondor

Location

Aurillac Cedex, France

Identifier

ORG-100050526

Address

50 Avenue De La Republique, 15002, France

Departments

94000
Anesthésie-Réanimation
cardiology
Chirurgie digestive et HPB
gastro-enterologie
Haematology
Hépato-Gastroentérologie
Hepatology
Médecine Interne
Médical Oncology
Oncologie
Oncologie médicale
Oncology
Psychiatrie et Addictologie
Réanimation
Urologie

Clinical trials at this site (19)

Search interface

Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled tr… Pending

2024-514633-38-00 Crohn’s Disease 5
Evaluation of Glucocorticoids Plus Rituximab Compared to Glucocorticoids Plus Placebo for the Treatment of Patients With Newly-Diagnosed or … Pending

2024-516052-17-01 Patients with a diagnosis of IgAV according to Chapel H 10
Shared decision-making in uncomplicated appendicitis: a pragmatic randomized trial comparing patient-driven choice (antibiotics only or appe… Pending

2025-520783-17-01 Adult patients diagnosed with uncomplicated acute appen 4
Impact of the timing of immunotherapy administration in metastatic lung cancers Pending

2025-521891-78-00 Adult patients with stage IV non squamous non-small cel 5
NoLEEta - Phase III non-inferiority trial of chemotherapy de-escalation in hormone receptorpositive, Her2-negative, intermediate-risk early … Recruiting

2025-520979-13-00 Patients with HR+ HER2- early breast cancer at intermed 5 2025-12-18
Renal Adjuvant MultiPle Arm Randomised Trial (RAMPART) Recruiting

2024-513219-29-00 Renal Cell Carcinoma 5 2024-10-21
A phase II study evaluating the efficacy of Selective Internal Radiation Therapy combined with Capecitabine in the neoadjuvant setting of Op… Recruiting

2024-516683-29-00 Biliary tract cancer 4 2022-02-04
ENGIC 06 (PRODIGE 114) – FFCD 2401 – FRUQUITAS Randomized phase III trial to compare trifluridine/tipiracil + Fruquintinib versus triflurid… Recruiting

2025-522395-92-00 metastatic oeso-gastric adenocarcinoma 5 2025-12-15
Dapagliflozine for cardio-renal protection at ICU discharge Recruiting

2024-510941-32-00 Adult patients discharged alive from ICU with a decreas 5 2025-12-02
Effect of long-term carvedilol to prevent decompensation or death in patients with asymptomatic Child-Pugh A5 to B8 cirrhosis and clinically… Recruiting

2024-511663-28-00 Asymptomatic Child-Pugh A5 to B8 cirrhosis 6 2025-09-11
ENGIC 01 - COLOSOTO: A single-arm phase II study evaluating 5-fluorouracil plus Panitumumab (anti-EGFR) and Sotorasib (KRAS G12C inhibitor) … Recruiting

2024-514030-20-00 colorectal cancer 4 2025-08-29
Efficacy and safety of bezafibrate 400 mg and bezafibrate 200 mg as adjunctive treatments in patients with primary biliary cholangitis and n… Recruiting

2023-504086-23-00 Subjects with PBC with a non-optimal response to UDCA. 5 2025-03-27
PRODIGE 90 - FFCD 22024 - PREDIR-NEOREC - Neoadjuvant dostarlimab with short course radiotherapy in a watch-and-wait strategy for microsatel… Recruiting

2024-510772-20-00 Rectal cancer locally advanced with microsatellite unst 4 2025-02-06
Dose individualization of chemotherapy in patients with gastrointestinal cancers lacking a specific liver enzyme Recruiting

2023-509963-25-00 Fluoropyrimidine (FP)-naive patients with gastrointesti 4 2025-01-17
A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha … Recruiting

2024-516109-21-00 Polycythaemia Vera (PV) 5 2024-12-09
Phase III randomized, multicenter open label clinical trial to evaluate the efficacy of immunomodulatory therapy in case of psychiatric diso… Recruiting

2024-518259-49-00 Mental Disorder 5 2024-07-04
Gut microbiome intervention with EXL01 in combination with nivolumab and FOLFOX as first-line treatment for patients with PD-L1 CPS ≥5 metas… Recruiting

2023-506753-38-00 metastatic gastric adenocarcinoma 4 2024-04-16
Weaning protocol for high-flow nasal oxygen therapy in the ICU - Multicenter randomized controlled trial. HiFloWEAN Recruiting

2023-504366-36-00 de novo acute respiratory failure 5 2024-02-17
Management of Anticoagulant Therapy monitored by an implantable device with telecardiology in patients with Acute Coronary Syndrome associat… Ended

2024-515433-15-02 acute coronary syndrome 6 2025-01-29